According to Reuters, the company Lundbeck announced the creation of Selincro - a new drug to combat alcohol abuse, which already gave European experts from the European medical Agency. Next year we expect that this tool on store shelves.
It is established that it produces blocking the action of opioid receptors in the brain. Despite the high demand for these drugs, it is still unknown whether Selincro be prescribed by doctors and is it possible active implementation of the company on the market. According to the latest forecasts, product sales in 2016 reached 95 million dollars.
In addition, at the end of next year we have the verdict of the European and North American experts, a relatively new antidepressant developed by Lundbeck together with a partner from Japan, company Таkеdа Phаrmаcеuticаl.
This tool can produce an explosion in the market, adding to the Treasury of 1-2 billion dollars per year. Mean vorticity, well-proven in clinical trials. In addition to impressive, he has a flexible dosing system.
Read also: 50 million to fight Alzheimer's disease
Also Lundbeck hopes to promote the release of drugs against schizophrenia Аbilify Мaintena (Inbox once a month) and the creation of tools to combat the symptoms of Alzheimer's disease. The following year was appointed the final stage of clinical trials of this drug.